Suppr超能文献

轻度创伤性脑损伤中世界卫生组织残疾评定量表2.0最小临床重要差异分数的推导

Derivation of a minimal clinically important difference score for the WHODAS 2.0 in mild traumatic brain injury.

作者信息

Snell Deborah L, Silverberg Noah D

机构信息

Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago Christchurch, Christchurch, New Zealand.

Department of Psychology, University of British Columbia, Vancouver, BC, Canada.

出版信息

NeuroRehabilitation. 2023;52(2):249-257. doi: 10.3233/NRE-220004.

Abstract

BACKGROUND

Mild traumatic brain injury (mTBI) treatment research is hindered by lack of clinically meaningful and responsive outcome measures. One promising measure is the World Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0), although minimal clinically important differences (MCID) for have not been established.

OBJECTIVE

To estimate MCID for the WHODAS 2.0 for mTBI.

METHODS

We analysed two prospectively collected mTBI datasets (n = 225) attending adult outpatient clinics in British Columbia, Canada. Participants completed the 12-item WHODAS 2.0, Patient Global Impression of Change scale, and Rivermead Post-Concussion Symptoms Questionnaire. We used anchor- and distribution-based methods to explore MCIDs in WHODAS 2.0 scores.

RESULTS

For Study 1 (n = 131), the anchor and distribution-based approaches produced minimal change estimates ranging from 1.3 to 2.8 interval scores. For Study 2 (n = 94), the anchor and distribution-based approaches produced minimal change estimates from 2.2 to 3.2 interval scores. For certain subgroups based on age, sex, and post-concussion severity, minimal change estimates were slightly higher.

CONCLUSION

An MCID of 3.5 interval WHODAS 2.0 points would conservatively capture meaningful change in adults of varying age, sex, and post-concussion symptom severity. Such a uniform metric will assist future mTBI intervention studies to improve standards of care and evaluation of outcomes.

摘要

背景

轻度创伤性脑损伤(mTBI)的治疗研究因缺乏具有临床意义且灵敏的结局指标而受到阻碍。世界卫生组织残疾评定量表2.0(WHODAS 2.0)是一项有前景的指标,尽管尚未确定其最小临床重要差异(MCID)。

目的

估计mTBI患者WHODAS 2.0的MCID。

方法

我们分析了两个前瞻性收集的mTBI数据集(n = 225),这些数据来自加拿大不列颠哥伦比亚省的成人门诊。参与者完成了12项WHODAS 2.0、患者整体变化印象量表和Rivermead脑震荡后症状问卷。我们使用基于锚定和分布的方法来探索WHODAS 2.0评分中的MCID。

结果

对于研究1(n = 131),基于锚定和分布的方法得出的最小变化估计值在1.3至2.8个区间分数之间。对于研究2(n = 94),基于锚定和分布的方法得出的最小变化估计值在2.2至3.2个区间分数之间。对于某些基于年龄、性别和脑震荡后严重程度的亚组,最小变化估计值略高。

结论

WHODAS 2.0评分的MCID为3.5个区间点,这将保守地反映不同年龄、性别和脑震荡后症状严重程度的成年人的有意义变化。这样一个统一的指标将有助于未来的mTBI干预研究提高护理标准和结局评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验